User: Guest  Login
Title:

[Current aspects of therapy conversion for multiple sclerosis].

Document type:
English Abstract; Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Kolber, P; Luessi, F; Meuth, S G; Klotz, L; Korn, T; Trebst, C; Tackenberg, B; Kieseier, B; Kümpfel, T; Fleischer, V; Tumani, H; Wildemann, B; Lang, M; Flachenecker, P; Meier, U; Brück, W; Limmroth, V; Haghikia, A; Hartung, H-P; Stangel, M; Hohlfeld, R; Hemmer, B; Gold, R; Wiendl, H; Zipp, F
Abstract:
In recent years the approval of new substances has led to a substantial increase in the number of course-modifying immunotherapies available for multiple sclerosis. Therapy conversion therefore represents an increasing challenge. The treatment options sometimes show complex adverse effect profiles and necessitate a long-term and comprehensive monitoring. This article presents an overview of therapy conversion of immunotherapies for multiple sclerosis in accordance with the recommendations of the...     »
Journal title abbreviation:
Nervenarzt
Year:
2015
Journal volume:
86
Journal issue:
10
Pages contribution:
1236-47
Language:
de
Fulltext / DOI:
doi:10.1007/s00115-015-4368-8
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/26269289
Print-ISSN:
0028-2804
TUM Institution:
Molekulare Immunologie (Prof. Knolle); Neurologische Klinik und Poliklinik
 BibTeX